Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sarah Pringle
Lack of Conventional Acinar Cells in Parotid Salivary Gland of Patient Taking an Anti-Pd-L1 Immune Checkpoint Inhibitor
Frontiers in Oncology
Cancer Research
Oncology
Related publications
Systemic Immunotherapy of Superficial Mouse Bladder Cancer With Avelumab (MSB0010718C), an Anti-Pd-L1 Immune Checkpoint Inhibitor
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
The Expression of PD-L1 in Salivary Gland Carcinomas
Scientific Reports
Multidisciplinary
Robust Antitumor Effects of Combined Anti-Cd4-Depleting Antibody and Anti-Pd-1/Pd-L1 Immune Checkpoint Antibody Treatment in Mice
Cancer immunology research
Cancer Research
Immunology
HDAC Inhibitor, CG-745, Enhances the Anti-Cancer Effect of Anti-Pd-1 Immune Checkpoint Inhibitor by Modulation of the Immune Microenvironment
Journal of Cancer
Oncology
Analysis of Blimp-1 and PD-1/PD-L1 Immune Checkpoint in an Autoimmune Thyroiditis Animal Model
International Journal of Endocrinology
Endocrine
Endocrinology
Metabolism
Autonomic Systems
Diabetes
Localization of Salivary Proteins in Granules of Human Parotid and Submandibular Acinar Cells
Critical Reviews in Oral Biology & Medicine
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Breast Care
Surgery
Oncology
The Safety and Tolerability of Combined Immune Checkpoint Inhibitors (Anti-Pd-1/Pd-L1 Plus Anti-Ctla-4): A Systematic Review and Meta-Analysis
BMC Cancer
Cancer Research
Oncology
Genetics
Crosslink Between Temozolomide and PD-L1 Immune-Checkpoint Inhibition in Glioblastoma Multiforme
BMC Cancer
Cancer Research
Oncology
Genetics